Biblio

Filters: Author is Carpenter, Paul A [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Cohen, J.A., Baldassari, L.E., Atkins, H.L., Bowen, J.D., Bredeson, C., Carpenter, P.A., Corboy, J.R., Freedman, M.S., Griffith, L.M., Lowsky, R., et al. (2019). AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR TREATMENT-REFRACTORY RELAPSING MULTIPLE SCLEROSIS: POSITION STATEMENT FROM THE AMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION.Biol Blood Marrow Transplant.

C

Kansagra, A.J., Frey, N.V., Bar, M., Laetsch, T.W., Carpenter, P.A., Savani, B.N., Heslop, H.E., Bollard, C.M., Komanduri, K.V., Gastineau, D.A., et al. (2018). Clinical utilization of Chimeric Antigen Receptors T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL) - an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transpl.Biol Blood Marrow Transplant.

E

Mielcarek, M., Furlong, T., Storer, B.E., Green, M.L., McDonald, G.B., Carpenter, P.A., Flowers, M.E.D., Storb, R., Boeckh, M., and Martin, P.J. (2015). Effectiveness and safety of lower-dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial.Haematologica.